News Release

Change in focus needed for progress in HIV-vaccine research

EMBARGO: 00:01H (London time) Wednesday September 28, 2005. In North America the embargo lifts at 6:30pm ET Tuesday September 27, 2005.

Peer-Reviewed Publication

The Lancet_DELETED

It is not time to give up on HIV vaccines but to change the way we pursue them, states a viewpoint published online today (Wednesday September 28, 2005) by THE LANCET.

Robert Gallo outlines seven major scientific obstacles that are blocking the development of a successful HIV-preventative vaccine. These include challenges with vaccine design and the lack of a truly useful animal model for studying HIV infection. Despite these problems Gallo states that it is not time to give up on HIV vaccines. He argues that in order to progress there should be a shift in emphasis to rational approaches that are based on solid knowledge of HIV biology.

Dr Gallo states: "…it is not time to give up on HIV vaccines but to change the way we pursue them. HIV-preventive vaccine research should clearly ignore empirically driven approaches and rely exclusively on rational approaches that are based on solid knowledge of HIV biology. I suggest after years of wandering, we have only begun to travel this path. A shift in emphasis to solving key scientific problems that have plagued the field is necessary."

He describes promising models by which this change in focus for vaccine research can be realised and administered, including the Gates's Foundation's Grand Challenge for Global Health--a scientist–driven programme to find practical solutions to major scientific roadblocks.

###

Contact: Dr Robert C Gallo, Institute of Human Virology, MRF Room S307, 725 West Lombard Street, Baltimore, MD 21201-1192, USA. T) +1 410 706 8614 gallo@umbi.umd.edu


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.